Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 372

1.

Race Plays a Role in the Knowledge, Attitudes, and Beliefs of Women with Osteoporosis.

Wright NC, Melton ME, Sohail M, Herbey I, Davies S, Levitan EB, Saag KG, Ivankova NV.

J Racial Ethn Health Disparities. 2019 Feb 11. doi: 10.1007/s40615-019-00569-w. [Epub ahead of print]

PMID:
30747331
2.

A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout.

Singh JA, Green C, Morgan S, Willig AL, Darnell B, Saag KG, Weiss R, Cutter G, McGwin G.

J Clin Rheumatol. 2019 Jan 23. doi: 10.1097/RHU.0000000000001004. [Epub ahead of print]

PMID:
30702450
3.

Sex differences in osteoporosis self-efficacy among community-residing older adults presenting for DXA.

Solimeo SL, Nguyen VT, Edmonds SW, Lou Y, Roblin DW, Saag KG, Cram P, Wolinsky FD.

Osteoporos Int. 2019 Jan 30. doi: 10.1007/s00198-019-04854-6. [Epub ahead of print]

PMID:
30701343
4.

Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial.

Mikuls TR, Cheetham TC, Levy GD, Rashid N, Kerimian A, Low KJ, Coburn BW, Redden DT, Saag KG, Foster PJ, Chen L, Curtis JR.

Am J Med. 2018 Nov 29. pii: S0002-9343(18)31134-3. doi: 10.1016/j.amjmed.2018.11.011. [Epub ahead of print]

PMID:
30503879
5.

Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts' consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation.

Hiligsmann M, Reginster JY, Tosteson ANA, Bukata SV, Saag KG, Gold DT, Halbout P, Jiwa F, Lewiecki EM, Pinto D, Adachi JD, Al-Daghri N, Bruyère O, Chandran M, Cooper C, Harvey NC, Einhorn TA, Kanis JA, Kendler DL, Messina OD, Rizzoli R, Si L, Silverman S.

Osteoporos Int. 2019 Jan;30(1):45-57. doi: 10.1007/s00198-018-4744-x. Epub 2018 Oct 31.

6.

Importance of Recent Fracture as Predictor of Imminent Fracture Risk.

Schnell AD, Curtis JR, Saag KG.

Curr Osteoporos Rep. 2018 Dec;16(6):738-745. doi: 10.1007/s11914-018-0487-z. Review.

PMID:
30368717
7.

Correction to: Hip fracture trends in the United States, 2002 to 2015.

Lewiecki EM, Wright NC, Curtis JR, Siris E, Gagel RF, Saag KG, Singer AJ, Steven PM, Adler RA.

Osteoporos Int. 2018 Nov;29(11):2583. doi: 10.1007/s00198-018-4685-4.

PMID:
30151621
8.

Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout.

Terkeltaub R, Saag KG, Goldfarb DS, Baumgartner S, Schechter BM, Valiyil R, Jalal D, Pillinger M, White WB.

Rheumatology (Oxford). 2019 Jan 1;58(1):61-69. doi: 10.1093/rheumatology/key245.

9.

Opioids vs Nonopioids for Chronic Back, Hip, or Knee Pain.

Singh JA, Curtis JR, Saag KG.

JAMA. 2018 Aug 7;320(5):508. doi: 10.1001/jama.2018.6937. No abstract available. Erratum in: JAMA. 2018 Sep 25;320(12):1288.

PMID:
30088001
10.

Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled Study.

Saag KG, Becker MA, Whelton A, Hunt B, Castillo M, Kisfalvi K, Gunawardhana L.

Arthritis Rheumatol. 2019 Jan;71(1):143-153. doi: 10.1002/art.40685.

PMID:
30073793
11.

Hypophosphatemia in the setting of metabolic bone disease: case reports and diagnostic algorithm.

Day AL, Morgan SL, Saag KG.

Ther Adv Musculoskelet Dis. 2018 Jul;10(7):151-156. doi: 10.1177/1759720X18779761. Epub 2018 Jun 15.

12.

Improving drug adherence in osteoporosis: an update on more recent studies.

Jaleel A, Saag KG, Danila MI.

Ther Adv Musculoskelet Dis. 2018 Jul;10(7):141-149. doi: 10.1177/1759720X18785539. Epub 2018 Jul 10. Review.

13.

A Performing Arts Intervention Improves Cognitive Dysfunction in 50 Hospitalized Older Adults.

Danila MI, Melnick JA, Mudano A, Flood K, Booth K, Kirklin K, Saag KG.

Innov Aging. 2018 Jun;2(2):igy013. doi: 10.1093/geroni/igy013. Epub 2018 Jun 18.

14.

ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis.

Bone HG, Cosman F, Miller PD, Williams GC, Hattersley G, Hu MY, Fitzpatrick LA, Mitlak B, Papapoulos S, Rizzoli R, Dore RK, Bilezikian JP, Saag KG.

J Clin Endocrinol Metab. 2018 Aug 1;103(8):2949-2957. doi: 10.1210/jc.2018-00163.

15.

Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in gout.

Bursill D, Taylor WJ, Terkeltaub R, Kuwabara M, Merriman TR, Grainger R, Pineda C, Louthrenoo W, Edwards NL, Andrés M, Vargas-Santos AB, Roddy E, Pascart T, Lin CT, Perez-Ruiz F, Tedeschi SK, Kim SC, Harrold LR, McCarthy G, Kumar N, Chapman PT, Tausche AK, Vazquez-Mellado J, Gutierrez M, Pinheiro GDRC, Richette P, Pascual E, Fisher MC, Burgos-Vargas R, Robinson PC, Singh JA, Jansen TL, Saag KG, Slot O, Uhlig T, Solomon DH, Keenan RT, Scire CA, Biernat-Kaluza E, Dehlin M, Nuki G, Schlesinger N, Janssen M, Stamp LK, Sivera F, Reginato AM, Jacobsson L, Lioté F, Ea HK, Rosenthal A, Bardin T, Choi HK, Hershfield MS, Czegley C, Choi SJ, Dalbeth N.

Arthritis Care Res (Hoboken). 2018 May 25. doi: 10.1002/acr.23607. [Epub ahead of print]

PMID:
29799677
16.

Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study.

Saag KG, Wagman RB, Geusens P, Adachi JD, Messina OD, Emkey R, Chapurlat R, Wang A, Pannacciulli N, Lems WF.

Lancet Diabetes Endocrinol. 2018 Jun;6(6):445-454. doi: 10.1016/S2213-8587(18)30075-5. Epub 2018 Apr 6.

PMID:
29631782
17.

Healthcare Providers' Recommendations for Physical Activity among US Arthritis Population: A Cross-Sectional Analysis by Race/Ethnicity.

Austin S, Saag KG, Pisu M.

Arthritis. 2018 Feb 4;2018:2807035. doi: 10.1155/2018/2807035. eCollection 2018.

18.

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.

White WB, Saag KG, Becker MA, Borer JS, Gorelick PB, Whelton A, Hunt B, Castillo M, Gunawardhana L; CARES Investigators.

N Engl J Med. 2018 Mar 29;378(13):1200-1210. doi: 10.1056/NEJMoa1710895. Epub 2018 Mar 12.

19.

Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitors.

Beukelman T, Xie F, Chen L, Horton DB, Lewis JD, Mamtani R, Mannion MM, Saag KG, Curtis JR.

Ann Rheum Dis. 2018 Jul;77(7):1012-1016. doi: 10.1136/annrheumdis-2017-212613. Epub 2018 Feb 9.

PMID:
29440001
20.

Is Rheumatoid Arthritis a Cardiovascular Risk-Equivalent to Diabetes Mellitus?

Curtis JR, Yang S, Singh JA, Xie F, Chen L, Yun H, Muntner P, Kent ST, Levitan EB, Safford MM, Saag KG, Zhang J.

Arthritis Care Res (Hoboken). 2018 Nov;70(11):1694-1699. doi: 10.1002/acr.23535.

PMID:
29409152

Supplemental Content

Loading ...
Support Center